There may soon be another COVID-19 vaccine on the market in the U.S. Novavax announced Monday that it has submitted a request to the Food and Drug Administration for emergency use authorization for its vaccine.
Novavax announced Monday that it has submitted a request to the Food and Drug Administration for emergency use authorization for its vaccine in adults."We believe our vaccine offers a differentiated option built on a well-understood protein-based vaccine platform that can be an alternative to the portfolio of available vaccines to help fight the COVID-19 pandemic," said Stanley C. Erck, president and CEO of Novavax.
In clinical trials, the company said its two-dose vaccine showed about a 90% efficacy against COVID-19. However, those trials were conducted prior to the omicron variant becoming the dominant strain. Novavax said the most common side effects were headache, nausea, injection site tenderness and fatigue. .Page-below > .RichTextModule {display:none;} .Page-below .Link {font-size: 12px; padding: 5px 10px;border: 1px solid #005687;border-radius: 4px;font-family:"proxima-nova", sans-serif; } Report a typo
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Moderna's COVID-19 vaccine gets full FDA approvalModerna's COVID-19 vaccine called “Spikevax” has been given full approval from the U.S. Food and Drug Administration.
Les mer »
Moderna COVID-19 vaccine gets full FDA approvalThe Moderna Covid-19 vaccine received full approval from the U.S. Food and Drug administration Monday, 11 months after the shot was given an emergency use authorization.
Les mer »
Moderna's COVID-19 vaccine granted full FDA approval, company saysModerna says the Food and Drug Administration has issued full approval for its COVID-19 vaccine for use in people aged 18 and older.
Les mer »
FDA Gives Moderna Full Approval for Its COVID-19 VaccineModerna says U.S. health regulators have given full approval to its COVID-19 vaccine after reviewing additional data on its safety and effectiveness
Les mer »